COMP <GO>
ADUS vs PRVA // EV/EBITDA & P/E VALUATION
Addus HomeCare Corporation (NASDAQ) VS. Privia Health Group Inc. (NASDAQ) • 15-METRIC TALLY: ADUS 4
— PRVA 3
▲ EV/EBITDA & P/E VALUATION LEADER: ADUS
LAST: $124.34 (+1.77%) • MKT CAP: $2.32B
valuation
16.8x
LAST: $22.00 (+0.71%) • MKT CAP: $2.81B
valuation
68.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADUS VS. PRVA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ADUS | PRVA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.10% | 10.50% | -1.40 | PRVA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 16.8x | 68.1x | -51.30 | ADUS | /valuation <GO> |
| Free Cash Flow Yield | 4.47% | 5.82% | -1.35 | PRVA | /fcf-yield <GO> |
| Operating Margin | 9.70% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 6.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 23.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | ADUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.1 | 48.9 | +24.20 | ADUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.3x | 114.0x | -93.70 | ADUS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.32B | $2.81B | -$487.6M | PRVA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ADUS REV | PRVA REV | ADUS GROSS % | PRVA GROSS % | ADUS FCF | PRVA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.42B | $0 | 32.5% | — | $103.8M | $163.4M |
| FY 2024 | $1.15B | $0 | 32.5% | — | $110.4M | $109.3M |
| FY 2023 | $1.06B | $0 | — | — | $112.2M | $80.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADUS // BETA —
PRVA // BETA —